Imipenem resistance among gram-negative bacilli

European Journal of Clinical Microbiology & Infectious Diseases

Volumn 13, Issue 3, 1994, Pages 203-204

  Quinn, J P ^a  

^a Diamond Inpatient Headache Unit   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM DERIVATIVE; IMIPENEM;

ANTIBIOTIC RESISTANCE; EDITORIAL; ENTEROBACTER CLOACAE; GRAM NEGATIVE BACTERIUM; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STENOTROPHOMONAS MALTOPHILIA;

DRUG RESISTANCE, MICROBIAL; GRAM-NEGATIVE BACTERIA; IMIPENEM; PSEUDOMONAS AERUGINOSA;

EID: 0028350628     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/BF01974537     Document Type: Editorial

References (21)

1. Outer membrane barrier as a mechanism of antimicrobial resistance
2. Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stability
3. Studies on the mechanism of action of imipenem (N-formimidolthienamycin) in vitro: binding to the penicillin-binding proteins (PBPs) in Escherichia coli and Pseudomonas aeruginosa, and inhibition of enzyme activities due to the PBPs in E. coli
4. Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections
5. Imipenem resistance in Pseudomonas aeruginosa resulting from diminished expression of an outer membrane protein
6. Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa
7. Protein D2 channel of the Pseudomonas aeruginosa outer membrane has a binding site for basic amino acids and peptides
8. Imipenem resistance in P. aeruginosa: mapping of the OprD2 gene
9. Cloning of the protein D2 gene of Pseudomonas aeruginosa and its functional expression in the imipenem-resistant host
10. Nucleotide sequence of the protein D2 gene of Pseudomonas aeruginosa
11. Mechanism of efficient elimination of protein D2 in outer membrane of imipenem-resistant Pseudomonas aeruginosa
12. Beta-lactamase lability and inducer power of newer beta-lactam antibiotics in relation to their activity against beta-lactamase-inducibility mutants of Pseudomonas aeruginosa
13. Purification and properties of inducible penicillin beta-lactamase isolated from Pseudomonas maltophilia
14. Transferable imipenem resistance in Pseudomonas aeruginosa
15. Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem
16. Imipenem- and meropenem-resistant mutants of Enterobacter cloacae and Proteus rettgeri lack porins
17. Imipenem resistance in Enterobacter
18. Imipenem / cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial
19. Therapy for lower respiratory tract infections with imipenem/cilastatin: a review of worldwide experience
20. Resistance to imipenem in Pseudomonas aeruginosa: clinical experience and biochemical mechanisms
21. Resistance to imipenem among selected gram-negative bacilli in the United States